Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF
Open Access
- 1 October 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (2) , 777-782
- https://doi.org/10.1111/j.1476-5381.1993.tb13879.x
Abstract
1 We have compared the receptors mediating the contractions of rings of rat thoracic aorta or rabbit pulmonary artery and rat stomach strips in response to the endothelin/sarafotoxin (ET/SX) family of peptides and to those mediating endothelium-dependent vasodilatations within the isolated perfused mesentery of the rat. To discriminate ETA receptors from ETB receptors we have used the criteria that ET-1 is more active than SX6c on ETA receptors, and that the ET/SX peptides are equiactive on ETB receptors. We have also assessed the effects of the ETA receptor-selective antagonist BQ-123, and the non-selective ET receptor antagonist PD 142893 on the responses of each preparation to the ET/SX peptides. 2 ET-1-induced constrictions of the rat thoracic aorta (EC50 3 × 10−10m), a prototypic ETA receptor-mediated response, or isolated perfused mesentery of the rat were antagonized by BQ-123 (10−5 m) or PD 142893 (10−5 m). SX6c did not constrict either the rat isolated perfused mesentery or the rat thoracic aorta. Thus, ETA receptors mediate these constrictions. 3 ET-1 and SX6c were approximately equipotent in constricting rabbit pulmonary artery rings (EC50s 3–6 × 10−10 m). Neither BQ-123 (10−5 m) nor PD 142893 antagonized the contractions induced by ET-1. These effects suggest mediation by ETB receptors but PD 142893 (10−5 m) did give a 3 fold antagonism of constrictions induced by SX6c. 4 SX6c was more potent than ET-1 in contracting the rat stomach strip (threshold concentrations 10−10 and 3 × 10−10 m). Contractions to ET-1 or SX6c were unaffected by BQ-123 (10−5 m), again indicative of ETB receptor-mediated events. PD 142893 (10−5 m) was ineffective against ET-1 but produced a 3 fold antagonism of SX6c. 5 In the rat isolated perfused mesentery ET-1 or SX6c (0.3–300 pmol) were equipotent in producing dose-related vasodilatations that were unaffected by BQ-123 (10−6 m), indicative of an ETB receptor-mediated response. In contrast to the other ETB-mediated responses, PD 142893 (10−6 m) strongly antagonized these vasodilatations. 6 Thus, ETA receptors mediate constrictions of the rat thoracic aorta and rat isolated perfused mesentery whereas ETB receptors mediate constrictions of the rabbit pulmonary artery and rat stomach strip and endothelium-dependent dilatations within the mesentery. However, within the group of ETB receptor-mediated responses, endothelium-dependent vasodilatations are sensitive to PD 142893, whereas contractions of the isolated smooth muscle preparations are not. Thus, the receptor present on the endothelium responsible for the release of nitric oxide in response to the ET/SX peptides is most probably different from that present on smooth muscle that mediates BQ-123-insensitive contractions.Keywords
This publication has 26 references indexed in Scilit:
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Venous smooth muscle contains vasoconstrictor ETB-like receptorsBiochemical and Biophysical Research Communications, 1992
- Endothelin and structurally related analogs distinguish between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1992
- [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activityBiochemical and Biophysical Research Communications, 1991
- Cloning and functional expression of human cDNA for the ETB endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Sarafotoxin S6c: An agonist which distinguishes between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1991
- Specific receptors for endothelin‐3 in cultured bovine endothelial cells and its cellular mechanism of actionFEBS Letters, 1990
- SRTX‐d, a new native peptide of the endothelin/sarafotoxin familyFEBS Letters, 1989
- Studies with Endothelin-3 and Endothelin-1 on Rat Blood Pressure and Isolated TissuesJournal of Cardiovascular Pharmacology, 1989
- Competitive interaction between endothelin and sarafotoxin: Binding and phosphoinositides hydrolysis in rat atria and brainBiochemical and Biophysical Research Communications, 1989